Venturicidin-type macrolides as FoF1-ATPase inhibitors: structure-activity relationships

被引：0
|
作者：
Tyurin, A. [1 ]
Alferova, V. [1 ]
Shuvalov, M. [1 ,2 ]
Novikov, R. [3 ,4 ]
机构：
[1] Gause Inst New Antibiot, Moscow, Russia
[2] Moscow MV Lomonosov State Univ, Dept Chem, Moscow, Russia
[3] Russian Acad Sci, Engelhardt Inst Mol Biol, Moscow, Russia
[4] Russian Acad Sci, Zelinsky Inst Organ Chem, Moscow, Russia
来源：
FEBS OPEN BIO | 2019年 / 9卷
关键词：
D O I：
暂无
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
P-07-008
引用
收藏
页码：137 / 137
页数：1
相关论文
共 50 条
  • [41] Quantitative structure-activity relationships of cyclin-dependent kinase 1 inhibitors
    A. V. Zakharov
    A. A. Lagunin
    D. A. Filimonov
    V. V. Poroikov
    Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, 2007, 1 (1) : 17 - 28
  • [42] Structure-activity Relationships for Bergenin Analogues as β-Secretase (BACE1) Inhibitors
    Kashima, Yusei
    Miyazawa, Mitsuo
    JOURNAL OF OLEO SCIENCE, 2013, 62 (06) : 391 - 401
  • [43] Synthesis and structure-activity relationships of 1-phenylpyrazoles as xanthine oxidase inhibitors
    Ishibuchi, S
    Morimoto, H
    Oe, T
    Ikebe, T
    Inoue, H
    Fukunari, A
    Kamezawa, M
    Yamada, I
    Naka, Y
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2001, 11 (07) : 879 - 882
  • [44] Structure-activity relationships of Na,K-ATPase and H,K-ATPase
    De Pont, JJHHM
    Koenderink, JB
    Swarts, HGP
    Willems, PHGM
    MECHANISMS AND CONSEQUENCES OF PROTON TRANSPORT, 2002, : 71 - 82
  • [45] Synthesis and structure-activity relationships of di- and trisaccharide inhibitors for Shiga-like toxin Type 1
    Kitov, PI
    Bundle, DR
    JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 2001, (08): : 838 - 853
  • [46] Structure-Activity Relationships and Mechanism of Action of Macrolides Derived from Erythromycin as Antibacterial Agents
    Liang, Jian-Hua
    Han, Xu
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2013, 13 (24) : 3131 - 3164
  • [47] Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1
    Passic, Shendra R.
    Ferguson, Mary Lee
    Catalone, Bradley J.
    Kish-Catalone, Tina
    Kholodovych, Vladyslav
    Zhu, Wei
    Welsh, William
    Rando, Robert
    Howett, Mary K.
    Wigdahl, Brian
    Labib, Mohamed
    Krebs, Fred C.
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (10) : 723 - 732
  • [48] Deciphering structure-activity relationships in a series of Tat/TAR inhibitors
    Pascale, Lise
    Lopez Gonzalez, Alejandro
    Di Giorgio, Audrey
    Gaysinski, Marc
    Teixido Closa, Jordi
    Estrada Tejedor, Roger
    Azoulay, Stephane
    Patino, Nadia
    JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS, 2016, 34 (11): : 2327 - 2338
  • [49] Synthesis and structure-activity relationships of benzophenones as inhibitors of cathepsin D
    Whitesitt, CA
    Simon, RL
    Reel, JK
    Sigmund, SK
    Phillips, ML
    Shadle, JK
    Heinz, LJ
    Koppel, GA
    Hunden, DC
    Lifer, SL
    Berry, D
    Ray, J
    Little, SP
    Liu, XD
    Marshall, WS
    Panetta, JA
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (18) : 2157 - 2162
  • [50] Structure-activity relationships for synthetic peptide inhibitors of thrombin.
    Clement, CC
    Philipp, M
    Gingold, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U214 - U214
12345